Cargando…
HAE patient self-sampling for biomarker establishment
BACKGROUND: Hereditary Angioedema (HAE) is a genetic disorder that leads to frequent angioedema attacks in various parts of the body. In most cases it is caused by pathogenic variants in the SERPING1 gene, coding for C1-Inhibitor (C1-INH). The pathogenic variants in the gene result in reduced C1-INH...
Autores principales: | Förster, Toni M., Magerl, Markus, Maurer, Marcus, Zülbahar, Selen, Zielke, Susanne, Inhaber, Neil, Crocetta, Donatello, Rolfs, Arndt, Skrahina, Volha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478266/ https://www.ncbi.nlm.nih.gov/pubmed/34583739 http://dx.doi.org/10.1186/s13023-021-02021-x |
Ejemplares similares
-
Long-term prophylaxis with lanadelumab for HAE: authorization for temporary use in France
por: Fain, Olivier, et al.
Publicado: (2022) -
Microbial contamination and composition of oral samples subjected to clinical whole genome sequencing
por: Kumar, Abhishek, et al.
Publicado: (2023) -
The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings
por: Skrahina, Volha, et al.
Publicado: (2020) -
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022) -
Genotype-phenotype correlations of cystic fibrosis in siblings compound heterozygotes for rare variant combinations: Review of literature and case report
por: Tkemaladze, Tinatin, et al.
Publicado: (2022)